Loading company…
PBD Biotech Ltd of Suffolk, UK, develops bacteriophage-based diagnostics, with its Actiphage test detecting tuberculosis-causing mycobacteria.
Founded in 2014 and headquartered in Suffolk, UK, PBD Biotech develops diagnostics for mycobacteria, including the Actiphage test for tuberculosis in blood samples, used in human and veterinary medicine. Its customers include healthcare providers, diagnostic labs and government health agencies. On March 26, 2021, it raised GBP 2.3 million from investors including the British Business Bank and Foresight Group Holdings. Jane Theaker is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in